Although FXR activation has a protective effect on steatosis, some other voices also revealed that intestinal FXR promotes diet-induced obesity and steatosis (Wang et al., 2018; Krautkramer et al., 2021). This evidence concerns the gene NR1H4 and obesity due to melanocortin 4 receptor deficiency.